BCL2 and neoplasm: Because anti-tumor miR-24 promotes differentiation, growth arrest and apoptosis through repression of AURKB, BCL2, CCNA2, CDC2, CDK4, E2F2, MYC, and XIAP (Figure 3A), tumor suppressor miR-24 is downregulated in human cancers.